冠状动脉旁路移植术中缺血性二尖瓣反流的当代管理
基于全州协作数据库(2011-2020年)接受冠状动脉旁路移植术的患者,按缺血性二尖瓣反流严重程度分层,评估二尖瓣干预趋势。中度反流患者接受二尖瓣干预的比例随时间下降(2011年17.7% vs 2020年7.5%,Ptrend=.001),重度反流患者二尖瓣置换率保持稳定(11.1% vs 13.3%,Ptrend=.14)。倾向性匹配分析显示二尖瓣干预未增加手术死亡率和主要并发症。
要点
- 中度缺血性二尖瓣反流患者接受二尖瓣干预的比例从2011年17.7%降至2020年7.5%(Ptrend=.001)。
- 重度缺血性二尖瓣反流患者二尖瓣置换率保持稳定(2011年11.1% vs 2020年13.3%,Ptrend=.14)。
- 倾向性匹配分析中,二尖瓣干预未增加主要并发症(29.3% vs 23.7%,P=.16)或手术死亡率(1.2% vs 2.4%,P=.5)。
核心结论
- 与近期指南更新一致,中度缺血性二尖瓣反流患者接受二尖瓣修复的比例下降,但重度反流患者的二尖瓣置换率未变化。
- 冠状动脉旁路移植术中行二尖瓣干预未增加手术死亡率或主要并发症。
研究设计与样本
- 回顾性分析全州协作数据库(2011-2020年)中接受冠状动脉旁路移植术的患者,按缺血性二尖瓣反流严重程度分层。
- 共纳入11,676例患者,其中中度缺血性二尖瓣反流1,355例(11.6%),重度390例(3.3%)。
- 采用倾向性评分匹配分析比较接受与未接受二尖瓣干预的患者,匹配后共249对。
主要发现
- 中度缺血性二尖瓣反流患者接受二尖瓣干预的比例从2011年17.7%下降至2020年7.5%(Ptrend=.001)。
- 重度缺血性二尖瓣反流患者接受二尖瓣置换的比例保持稳定(2011年11.1% vs 2020年13.3%,Ptrend=.14)。
- 中度缺血性二尖瓣反流患者中,接受二尖瓣干预者主要并发症发生率高于未干预者(29.1% vs 19.9%,P=.005)。
- 倾向性匹配分析(249对)中,二尖瓣干预组与未干预组主要并发症无显著差异(29.3% vs 23.7%,P=.16),手术死亡率也无显著差异(1.2% vs 2.4%,P=.5)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent guidelines for the treatment of moderate or severe ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed. This study assessed the real-world impact of changing guidelines on the management of IMR during CABG over time. We hypothesized that the utilization of mitral valve repair for IMR would decrease over time, whereas mitral valve replacement for severe IMR would increase. METHODS: Patients undergoing CABG in a statewide collaborative database (2011-2020) were stratified by severity of IMR. Trends in mitral valve repair or replacement were evaluated. To account for differences of the patients, propensity score-matched analyses were used to compare patients with and without mitral intervention. RESULTS: A total of 11,676 patients met inclusion criteria, including 1355 (11.6%) with moderate IMR and 390 (3.3%) with severe IMR. The proportion of patients undergoing mitral intervention for moderate IMR decreased over time (2011, 17.7%; 2020, 7.5%; Ptrend = .001), whereas mitral replacement for severe IMR remained stable (2011, 11.1%; 2020, 13.3%; Ptrend = .14). Major morbidity was higher for patients with moderate IMR who underwent mitral intervention (29.1% vs 19.9%; P = .005). In a propensity analysis of 249 well-matched pairs, there was no difference in major morbidity (29.3% with mitral intervention vs 23.7% without; P = .16) or operative mortality (1.2% vs 2.4%; P = .5). CONCLUSIONS: Consistent with recent guideline updates, patients with moderate IMR were less likely to undergo mitral repair. However, the rate of replacement for severe IMR did not change. Mitral intervention during CABG did not increase operative mortality or morbidity.
引用
- Pienta MJ, Theurer P, He C, et al. Contemporary Management of Ischemic Mitral Regurgitation at Coronary Artery Bypass Grafting. Ann Thorac Surg. 2022. PMID: 36150477. doi:10.1016/j.athoracsur.2022.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。